» Authors » Sherry Shariatmadar

Sherry Shariatmadar

Explore the profile of Sherry Shariatmadar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 131
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gammon R, Alcorn K, Friedman M, Hogan S, Manwanga S, Marinaro L, et al.
Transfus Apher Sci . 2022 Nov; 61(6):103597. PMID: 36328944
Although a subspecialty-trained transfusion medicine (TM) physician brings value to the clinical bedside, hospital transfusion service oversight often falls under the responsibility of pathologists primarily focused on surgical pathology. Yet,...
2.
Ramirez G, Gautam-Goyal P, Shariatmadar S, Khatri A, McCann-Pineo M, Rasul R, et al.
Transfusion . 2022 Feb; 62(4):764-769. PMID: 35191047
Background: Although over 5000 platelet transfusions occur daily in the United States, the presence of SARS-CoV-2 antibodies in platelet units is not commonly evaluated for. The effects of platelet transfusions...
3.
Chhibber V, Fischman J, Benedetto A, Nikolis N, Indrikovs A, Shariatmadar S
Transfusion . 2020 Jun; 60(7):1356-1363. PMID: 32500565
Currently there are no widely accepted guidelines regarding the appropriate use of O- red blood cells (RBCs). Although there has been a decline in overall RBC utilization since 2010, the...
4.
Jethava A, Olivares E, Shariatmadar S
Case Rep Pediatr . 2015 Dec; 2015:897803. PMID: 26682081
Anti-Di(a) is a clinically significant red cell antibody known to cause hemolytic disease of the newborn. Here, we report on a case of mild hemolytic disease of the newborn caused...
5.
Allen C, Shariatmadar S, Meizoso J, Hanna M, Mora J, Ray J, et al.
J Surg Res . 2015 Jul; 199(2):622-8. PMID: 26182996
Background: A massive transfusion protocol (MTP) presents a logistical challenge for most blood banks and trauma centers. We compare the ratio of packed red blood cells (PRBC) and plasma transfused...
6.
Allen C, Tashiro J, Valle E, Thorson C, Shariatmadar S, Schulman C, et al.
J Pediatr Surg . 2014 Dec; 49(11):1678-82. PMID: 25475817
Purpose: Initial hematocrit (Hct) is generally not considered a marker of acute blood loss because it is assumed that physiologic response of fluid conservation to hemorrhage is delayed. We challenged...
7.
Bayraktar S, Eileen B, Shariatmadar S, Lian E
BMJ Case Rep . 2012 Jul; 2010. PMID: 22798444
We report a case of concurrent thrombotic thrombocytopenic purpura (TTP) and immune thrombocytopenic purpura (ITP) in a 63-year-old woman who had been receiving treatment with bevacizumab for metastatic neuroendocrine tumour...
8.
Jy W, Ricci M, Shariatmadar S, Gomez-Marin O, Horstman L, Ahn Y
Transfusion . 2011 Apr; 51(4):886-93. PMID: 21496051
This article reviews evidence for the involvement of cell-derived microparticles (MPs) in transfusion-related adverse events. The controversy concerning possible added risk of older versus fresher stored blood is also reviewed...
9.
Sharma S, Shariatmadar S, Krishan A
Cytometry B Clin Cytom . 2010 Jan; 78(2):123-9. PMID: 20091711
Background: Over-expression of aldehyde dehydrogenase and other stem cell markers is characteristic of cells with tumorigenic potential in NOD/SCID mice. Most of these studies have focused on metastatic cells in...
10.
Shariatmadar S, Sharma S, Cabana R, Powell S, Ruiz P, Krishan A
Cytometry B Clin Cytom . 2008 Apr; 74(3):182-8. PMID: 18383271
Background: The authors have used a flow analyzer to measure electronic cellular volume of peripheral blood hematopoietic stem/progenitor cells obtained by granulocyte-colony stimulating factor (G-CSF) mobilization and apheresis (HPC-A) of...